Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.2376
-0.0128 (-5.11%)
May 23, 2025, 5:29 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 364.05 million as of May 23, 2025. Its market cap has increased by 19.01% in one year.
Market Cap
364.05M
Enterprise Value
488.94M
Revenue
277.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 364.05M, an increase of 177.78%. That is a compound annual growth rate of 11.60%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 106.47B |
| Sectra AB | 61.81B |
| Getinge AB | 52.47B |
| Asker Healthcare Group AB | 37.62B |
| Medicover AB | 36.61B |
| Camurus AB | 30.99B |
| AddLife AB | 22.46B |
| Vitrolife AB | 21.33B |